Carcinoma, Small Cell

Also known as: Small Cell Carcinoma / Small cell carcinoma (disorder) / Small cell neuroendocrine carcinoma (morphologic abnormality) / Oat cell carcinoma (morphologic abnormality) / Oat cell carcinoma / Small cell carcinoma (morphologic abnormality)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB03496Alvocidib1Terminated1
DB15770Cosibelimab1Recruiting1
DB16895GSK-28795521Terminated1
DB00540Nortriptyline1Completed1
DB01229Paclitaxel1Completed1
DB09037Pembrolizumab1Active Not Recruiting1
DB06176Romidepsin1Terminated1
DB00398Sorafenib1Completed1
DB01030Topotecan1Completed1
DB15387Bintrafusp alfa1 / 2Recruiting1
DB00515Cisplatin1 / 2Completed2
DB00515Cisplatin1 / 2Terminated2
DB00773Etoposide1 / 2Completed1
DB00773Etoposide1 / 2Terminated1
DB17204P-2045 Re-1881 / 2Recruiting1
DB09037Pembrolizumab1 / 2Active Not Recruiting1
DB00642Pemetrexed1 / 2Terminated1
DB12257Platinum1 / 2Completed1
DB08910Pomalidomide1 / 2Terminated1
DB05654Sagopilone1 / 2Completed1
DB12391Sagopilone1 / 2Completed1
DB00853Temozolomide1 / 2Recruiting1
DB01030Topotecan1 / 2Recruiting1
DB07232Veliparib1 / 2Completed1
DB11901Apalutamide2Active Not Recruiting1
DB01169Arsenic trioxide2Completed1
DB16107BI 25362Completed1
DB09258Bemiparin2Terminated1
DB00958Carboplatin2Completed2
DB15421Cetrelimab2Active Not Recruiting1
DB00515Cisplatin2Completed1
DB00997Doxorubicin2Completed1
DB00773Etoposide2Completed1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Terminated1
DB00762Irinotecan2Completed1
DB12222Lurtotecan2Completed1
DB01229Paclitaxel2Completed1
DB09037Pembrolizumab2Active Not Recruiting1
DB00642Pemetrexed2Completed2
DB00642Pemetrexed2Terminated1
DB12060RRx-0012Completed1
DB00853Temozolomide2Unknown Status1
DB12200Tivantinib2Terminated1
DB01030Topotecan2Completed2
DB11641Vinflunine2Completed1
DB00361Vinorelbine2Completed1
DB11999Vosaroxin2Completed1
DB12459Belotecan3Completed1
DB00515Cisplatin3Completed1
DB00773Etoposide3Completed1